Comparison
Osteoarthritis vs rheumatoid arthritis
Both of these get called arthritis, and they aren't one disease with two names. One is joint damage from wear over years. The other is an immune system that has misread the lining of your own joints.
What the research found.
One review pooled 37 studies and 14,949 patients. Anti-CCP was positive in 67 percent of people with rheumatoid arthritis, between 62 and 72. So roughly a third of people with the disease test negative on it.
In that review, anti-CCP cleared 95 percent of the people who didn't have the disease, with the range running from 94 to 97. Rheumatoid factor cleared 85 percent, between 82 and 88. That ten-point gap is why a positive anti-CCP counts for more.
Two rheumatoid arthritis databases recorded the first measurement. CRP was under 10 mg/L in 44 percent of one group, and in the other it was 58 percent. All three of ESR, CRP, and rheumatoid factor read normal in about 15 percent.
Marine oil supplements lowered arthritis pain across 22 rheumatoid arthritis trials, at a pooled effect of minus 0.21. Across 5 osteoarthritis trials the review found nothing at all. That figure was minus 0.17, and its range crossed zero.
The short answer.
They're separate diseases that happen to affect joints. Osteoarthritis is damage to the cartilage in load-bearing joints, and it builds up over years, where the pain is worse after use and better with rest. It isn't mainly an immune disease at all.
Rheumatoid arthritis is an autoimmune disease, where the immune system has misread the synovium, which is the lining of the joint. It tends to pick small joints in the hands and feet, it tends to hit the two sides of the body alike, and it produces morning stiffness that lasts.
The difference decides the treatment entirely. Rheumatoid arthritis gets treated with drugs that damp the immune process down, and starting them early changes the long-term outcome. Osteoarthritis doesn't get treated that way, because there's no immune process to damp down.
Side by side.
| Osteoarthritis | Rheumatoid arthritis | What it tells you | |
|---|---|---|---|
| What causes it | Cartilage wears down under load | The immune system has misread the joint lining | One is wear, the other is a misreading |
| Which joints | Knees, hips, the base of the thumb, the spine | Small joints of the hands and feet, and wrists | Load-bearing against small and matched |
| Across the body | Often one side, or the side you use more | Usually the matching joints on both sides | Both sides points to rheumatoid arthritis |
| Morning stiffness | Under 30 minutes, and it eases quickly | An hour or longer, sometimes most of the morning | How long it lasts is one of the best questions |
| What makes it worse | Using the joint, later in the day | Rest. It gets better with movement | The two run in opposite directions |
| Blood tests | Normal, because nothing is inflamed body-wide | Anti-CCP or rheumatoid factor may be positive | A positive anti-CCP is strong. A negative one isn't an all-clear |
| Effects beyond the joint | None. The problem stays in the joint | Tiredness, weight loss, lung and eye trouble | Whole-body symptoms point away from osteoarthritis |
| What treatment does | Manages pain and keeps the joint working | Damps the immune process down and prevents damage | Early treatment counts far more in one of them |
Two diseases with one name
The word arthritis covers both of these, and it hides the thing that counts most about them. Osteoarthritis is damage to the cartilage in a joint, built up over years under load. Rheumatoid arthritis is an autoimmune disease, where the immune system has misread the synovium, which is the thin lining covering the inside of the joint.
That difference isn't academic, because it decides what treatment can achieve. In rheumatoid arthritis there's an immune process to interrupt, and interrupting it early protects the joint from damage that would otherwise be permanent. In osteoarthritis there's no immune process to damp down, so treatment aims at pain, at function, and at keeping the joint working.
People come to this comparison having been told they have arthritis and wanting to know which kind. Three things usually point one way, and they are which joints are involved, how long the morning stiffness lasts, and whether anything else in the body is affected. The blood tests support that reading rather than replacing it, so this page sets the two side by side and you can see which description fits.
Which joints are involved does most of the work
Osteoarthritis picks joints that take load, and the usual sites are knees, hips, the base of the thumb, and the spine. Whichever joints have done the most work are the ones that complain. It's often worse on one side, and that's usually the side of an old injury or the side you favor without thinking about it.
Rheumatoid arthritis picks small joints, and most often that's the knuckles and the middle joints of the fingers. It picks the wrists and the small joints of the feet too, and it tends to hit the two sides alike, so both hands are involved rather than one. So watch for matched small joints on both sides, because it's one of the more useful things to notice about your own hands.
The direction of the pain is the other clue, and it runs opposite ways. Wear pain gets worse the more you use the joint and better when you rest it, so the end of the day is the worst part. Inflammatory pain is worst after a rest, which is why the morning is the hard part and why moving around gradually improves it.
What the blood tests can and can't settle
Anti-CCP is the most useful single test for rheumatoid arthritis, and its value is in the positive result rather than the negative one. One review pooled 37 studies and 14,949 patients, where the test cleared 95 percent of the people who didn't have the disease, between 94 and 97, while rheumatoid factor cleared 85 percent, between 82 and 88. So a positive anti-CCP in somebody with swollen small joints is strong evidence, and that difference is the whole reason it counts for more than the older test.
The limit on this test sits on the other side of it. That review put the catch rate at 67 percent, between 62 and 72, so roughly a third of people who have rheumatoid arthritis test negative. Seronegative disease is real and it's common, and it means the disease with negative blood tests, so a negative antibody test in somebody whose joints look inflamed doesn't close the question.
The inflammation markers are less decisive than most people expect. Two ordinary-care databases recorded the first measurement, where CRP was under 10 mg/L in 44 percent of one group and 58 percent of the other, and both ESR and CRP read normal in a third to two fifths of them. All three of ESR, CRP, and rheumatoid factor read normal in about 15 percent, so normal results describe the moment they were taken rather than ruling the disease out.
Where the evidence for treatment separates them
The clearest example comes from a place people don't expect, which is a review of fish oil. Across 22 trials in rheumatoid arthritis, marine oil supplements lowered pain, at a pooled effect of minus 0.21 whose upper limit was minus 0.004. Across 5 trials in osteoarthritis the review found nothing, at minus 0.17, with a range running from minus 0.57 to 0.24.
Two things are worth saying about that rather than one. The first is that the split is what the mechanism predicts, because a supplement acting on inflammatory routes has something to act on in one disease and less to act on in the other. The second is that the rheumatoid arthritis effect is genuinely fragile, with an upper limit of minus 0.004 that barely clears no effect, and function didn't improve in either group.
Exercise is where the two come together rather than apart. The 2018 EULAR recommendations concluded that ordinary public health advice on physical activity applies to people with inflammatory arthritis and applies to people with osteoarthritis alike. That's a guideline rather than a trial, so it comes with no effect size, and what it settles is that neither diagnosis is a reason to move less.
Why getting it right early counts more in one of them
An osteoarthritic knee assessed a year late is a knee that hurt a year longer than it needed to. A rheumatoid joint assessed a year late can be a joint with damage that treatment can no longer undo, because the immune process has been running the whole time. That imbalance is the practical reason the two are worth telling apart quickly.
One combination deserves a prompt appointment, which is swelling in the small joints of both hands, morning stiffness lasting an hour or more, and tiredness out of proportion to what you've been doing. Each of those three has other explanations on its own. Together they describe something worth having looked at rather than watched, and a doctor would far rather see it early and find nothing than see it late.
Having one condition doesn't protect anyone from the other, and that complicates things later on. Joints damaged by rheumatoid arthritis go on to develop wear problems on top of the inflammatory ones, so pain in a long-standing joint has to be assessed rather than assumed. Working out which of the two is causing a problem decides the answer, because it decides whether the immune system comes into it at all.
When each one fits.
- Think osteoarthritis if the pain is in knees, hips, or the base of the thumb, if it's worse after using the joint, and if the stiffness clears within half an hour of getting up.
- Think rheumatoid arthritis if small joints in both hands are swollen, if the stiffness lasts an hour or more, and if moving around makes it better rather than worse.
- Get swelling in the small joints looked at promptly rather than waiting, because the treatments that prevent joint damage work best when they start early.
- Mention tiredness, weight loss, dry eyes, or breathlessness, since those point toward a body-wide disease rather than a wear problem.
- Ask what a normal blood test means in your case, because normal inflammation markers don't rule rheumatoid arthritis out and a lot of people assume they do.
- Remember that having one doesn't protect you from the other, since plenty of people with rheumatoid arthritis get osteoarthritis as well.
Questions patients ask.
Can a blood test tell me which one I have?
It helps, and it doesn't decide it. A positive anti-CCP is strong evidence for rheumatoid arthritis, because that test cleared 95 percent of the people who didn't have the disease, while rheumatoid factor cleared 85 percent. The trouble is at the other end, where anti-CCP is positive in only about 67 percent of people who have it, so a negative result leaves roughly a third unexplained. That's why the joints involved still do a lot of the work, and so does how long the trouble has run.
My inflammation markers were normal. Does that rule out rheumatoid arthritis?
No, and this is one of the commonest mistakes about the diagnosis. Two ordinary-care databases recorded the first measurement, where CRP was under 10 mg/L in 44 percent of one group and 58 percent of the other. All three read normal in about 15 percent of them, those three being ESR, CRP, and rheumatoid factor, so normal results say something about right now rather than being a diagnosis.
Why does morning stiffness count for so much?
Because the two produce it for different reasons. Inflammatory stiffness comes from the swollen joint lining, it lasts an hour or more, and movement gradually improves it. Wear stiffness in osteoarthritis eases within about half an hour. It comes back after you've used the joint, so when a doctor asks how long it takes you to loosen up in the morning, that's the question underneath the question.
Does diet help either of them?
The best trial evidence separates them, which is informative in itself. One review pooled marine oil trials, where pain fell a little across 22 rheumatoid arthritis trials, at a pooled effect of minus 0.21 whose upper limit was minus 0.004. That barely clears no effect at all, and the review found nothing in osteoarthritis across 5 trials. Function didn't improve in either group, and an effect that small sits below what most people would notice.
Should I exercise if I have either one?
Yes, and the European guideline covers both together rather than splitting them. The 2018 EULAR recommendations said that ordinary public health advice on exercise applies to inflammatory arthritis and applies to osteoarthritis too. That guideline rests on a review plus expert agreement rather than on one trial, so it comes with no effect size. What it does say is that neither one is a reason to stop moving.
Can I have both at the same time?
Yes, and it's common enough to expect. Rheumatoid arthritis damages joints over time, damaged joints then develop wear problems, so the two build up together in one person. That's part of why a flare has to be assessed rather than assumed, because pain in a long-standing rheumatoid joint might be inflammation that needs treatment or wear that doesn't. Sorting out which one is happening changes the answer.
Is osteoarthritis just wear and tear from getting older?
That's the usual shorthand, and it undersells what's going on. Age is the biggest single risk factor, and so is joint injury, so is body weight, and so is the load a particular joint has taken over a lifetime. It isn't simply the miles you've walked, because two people of the same age and a similar history end up in different places. What's reliable is where the process sits, which is centered on cartilage in the joint rather than on an immune process from elsewhere.
References.
- Nishimura K; Sugiyama D; Kogata Y et al. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Annals of internal medicine. 2007;146:797-808. 10.7326/0003-4819-146-11-200706050-00008Diagnostic accuracy meta-analysis
- Sokka T; Pincus T. Erythrocyte sedimentation rate, C-reactive protein, or rheumatoid factor are normal at presentation in 35%-45% of patients with rheumatoid arthritis seen between 1980 and 2004: analyses from Finland and the United States. The Journal of rheumatology. 2009;36:1387-90. 10.3899/jrheum.080770Retrospective analysis of two consecutive usual-care RA databases
- Senftleber NK; Nielsen SM; Andersen JR et al. Marine Oil Supplements for Arthritis Pain: A Systematic Review and Meta-Analysis of Randomized Trials. Nutrients. 2017;9. 10.3390/nu9010042Systematic review and meta-analysis of randomised trials
- Rausch Osthoff A; Niedermann K; Braun J et al. 2018 EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis. Annals of the Rheumatic Diseases. 2018;77:1251-1260. 10.1136/annrheumdis-2018-213585EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis
This page gathers the published research on this subject into one place. The studies behind it were published between 1989 and 2026, and every figure links to the paper it came from. Those studies were peer reviewed. This summary of them was not. Dr. Sarah Luebker is reviewing these pages one at a time and has not reached this one yet, so it carries no medical review date and nothing here is her opinion or her advice to you. Each page gets updated as she reaches it. It is here in the meantime because the science is worth having in one organized place that is easy to find and easy to read. Talk to your own clinician before acting on any of it.